Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma.

Hellenthal NJ, Underwood W, Penetrante R, Litwin A, Zhang S, Wilding GE, Teh BT, Kim HL.

J Urol. 2010 Sep;184(3):859-64. doi: 10.1016/j.juro.2010.05.041.

PMID:
20643461
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma.

Thomas AA, Rini BI, Lane BR, Garcia J, Dreicer R, Klein EA, Novick AC, Campbell SC.

J Urol. 2009 Feb;181(2):518-23; discussion 523. doi: 10.1016/j.juro.2008.10.001. Epub 2008 Dec 18.

PMID:
19100579
[PubMed - indexed for MEDLINE]
3.

The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery.

Rini BI, Garcia J, Elson P, Wood L, Shah S, Stephenson A, Salem M, Gong M, Fergany A, Rabets J, Kaouk J, Krishnamurthi V, Klein E, Dreicer R, Campbell S.

J Urol. 2012 May;187(5):1548-54. doi: 10.1016/j.juro.2011.12.075. Epub 2012 Mar 14.

PMID:
22425095
[PubMed - indexed for MEDLINE]
4.

Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.

Shaw GL, Hussain M, Nair R, Bycroft J, Beltran L, Green JS, Powles T, Peters JL.

Urol Int. 2012;89(1):83-8. doi: 10.1159/000338057. Epub 2012 May 16.

PMID:
22614181
[PubMed - indexed for MEDLINE]
Free Article
5.

A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ.

Bex A, Blank C, Meinhardt W, van Tinteren H, Horenblas S, Haanen J.

Urology. 2011 Oct;78(4):832-7. doi: 10.1016/j.urology.2011.05.034. Epub 2011 Jul 29.

PMID:
21802123
[PubMed - indexed for MEDLINE]
6.

Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.

Seidel C, Fenner M, Merseburger AS, Reuter C, Ivanyi P, Länger F, Ganser A, Grünwald V.

World J Urol. 2011 Jun;29(3):355-60. doi: 10.1007/s00345-010-0642-3. Epub 2011 Jan 22.

PMID:
21258806
[PubMed - indexed for MEDLINE]
7.

Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery.

Gorin MA, Ekwenna O, Soloway MS, Ciancio G.

Urology. 2012 Feb;79(2):e11. doi: 10.1016/j.urology.2011.04.018. Epub 2011 Jun 15.

PMID:
21676439
[PubMed - indexed for MEDLINE]
8.

Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience.

Ansari J, Fatima A, Fernando K, Collins S, James ND, Porfiri E.

Oncol Rep. 2010 Aug;24(2):507-10.

PMID:
20596640
[PubMed - indexed for MEDLINE]
9.

Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.

Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CG.

J Urol. 2008 Jul;180(1):94-8. doi: 10.1016/j.juro.2008.03.047. Epub 2008 May 15.

PMID:
18485389
[PubMed - indexed for MEDLINE]
10.

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.

Powles T, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boleti E, Sahdev A, O'Brien T, Berney D, Beltran L, Nathan P, Haanen J, Bex A.

Eur Urol. 2011 Sep;60(3):448-54. doi: 10.1016/j.eururo.2011.05.028. Epub 2011 May 17.

PMID:
21612860
[PubMed - indexed for MEDLINE]
11.

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors.

Adams VR, Leggas M.

Clin Ther. 2007 Jul;29(7):1338-53. Review.

PMID:
17825686
[PubMed - indexed for MEDLINE]
12.

Sunitinib in patients with metastatic renal cell carcinoma.

Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD.

JAMA. 2006 Jun 7;295(21):2516-24.

PMID:
16757724
[PubMed - indexed for MEDLINE]
13.

Neoadjuvant sunitinib facilitates nephron-sparing surgery and avoids long-term dialysis in a patient with metachronous contralateral renal cell carcinoma.

Ansari J, Doherty A, McCafferty I, Wallace M, Deshmukh N, Porfiri E.

Clin Genitourin Cancer. 2009 Aug;7(2):E39-41. doi: 10.3816/CGC.2009.n.021.

PMID:
19692322
[PubMed - indexed for MEDLINE]
14.

Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy.

Dall'Oglio MF, Sousa-Canavez JM, Tanno FY, Tiseo BC, Crippa A, Dos Reis ST, Leite KR, Srougi M.

Int Braz J Urol. 2011 Mar-Apr;37(2):180-5; discussion 185-6.

PMID:
21557834
[PubMed - indexed for MEDLINE]
Free Article
15.

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study.

Garcia-Donas J, Esteban E, Leandro-García LJ, Castellano DE, del Alba AG, Climent MA, Arranz JA, Gallardo E, Puente J, Bellmunt J, Mellado B, Martínez E, Moreno F, Font A, Robledo M, Rodríguez-Antona C.

Lancet Oncol. 2011 Nov;12(12):1143-50. doi: 10.1016/S1470-2045(11)70266-2. Epub 2011 Oct 17.

PMID:
22015057
[PubMed - indexed for MEDLINE]
16.

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.

Bex A, van der Veldt AA, Blank C, van den Eertwegh AJ, Boven E, Horenblas S, Haanen J.

World J Urol. 2009 Aug;27(4):533-9. doi: 10.1007/s00345-008-0368-7. Epub 2009 Jan 15.

PMID:
19145434
[PubMed - indexed for MEDLINE]
17.

Sunitinib for treatment of advanced renal cell cancer: primary tumor response.

van der Veldt AA, Meijerink MR, van den Eertwegh AJ, Bex A, de Gast G, Haanen JB, Boven E.

Clin Cancer Res. 2008 Apr 15;14(8):2431-6. doi: 10.1158/1078-0432.CCR-07-4089.

PMID:
18413834
[PubMed - indexed for MEDLINE]
Free Article
18.

Sunitinib treatment in patients with severe renal function impairment: a report of four cases by the Hellenic Cooperative Oncology Group.

Lainakis G, Bamias A, Psimenou E, Fountzilas G, Dimopoulos MA.

Clin Nephrol. 2009 Jul;72(1):73-8.

PMID:
19640391
[PubMed - indexed for MEDLINE]
19.

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.

Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S, Hariharan S, Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski P, Mainwaring P, Nieto A, Yuan J, Bukowski R.

Lancet Oncol. 2009 Aug;10(8):757-63. doi: 10.1016/S1470-2045(09)70162-7. Epub 2009 Jul 15.

PMID:
19615940
[PubMed - indexed for MEDLINE]
20.

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.

Josephs D, Hutson TE, Cowey CL, Pickering LM, Larkin JM, Gore ME, Van Hemelrijck M, McDermott DF, Powles T, Chowdhury P, Karapetis C, Harper PG, Choueiri TK, Chowdhury S.

BJU Int. 2011 Oct;108(8):1279-83. doi: 10.1111/j.1464-410X.2010.09990.x. Epub 2011 Jan 18.

PMID:
21244613
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk